This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
When Does Market Timing Actually Work? - October 03, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Cantel Medical Enters Oversold Territory
by Zacks Equity Research
Cantel Medical Corp. (CMD) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Cantel (CMD) Upgraded to Strong Buy: Here's What You Should Know
by Zacks Equity Research
Cantel (CMD) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Cantel Medical (CMD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 3.28% and 0.37%, respectively, for the quarter ended July 2019. Do the numbers hold clues to what lies ahead for the stock?
The Truth About Market Timing - September 13, 2019
by Zacks Equity Research
Is the ability to time the markets more of a data-driven science or a 'gut - feeling' art?
Yes, You Can Time the Market. Find out How - August 26, 2019
by Zacks Equity Research
Have you ever dreamed of being that one in a million investor who has the talent to perfectly time the markets?
Simple Market Timing Strategies That Work - August 05, 2019
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
New Strong Sell Stocks for June 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
New Strong Sell Stocks for June 12th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Company News For Jun 5, 2019
by Zacks Equity Research
Companies In The News Are: TIF,VTR,NAV,CMD
Cantel Medical (CMD) Meets Q3 Earnings Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 0.00% and 1.15%, respectively, for the quarter ended April 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cantel Medical (CMD) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical (CMD) Q1 Earnings Surpass Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 3.33% and -0.93%, respectively, for the quarter ended October 2018. Do the numbers hold clues to what lies ahead for the stock?
Cantel Medical (CMD) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical (CMD) Meets Q4 Earnings Estimates
by Zacks Equity Research
Cantel (CMD) delivered earnings and revenue surprises of 0.00% and 0.77%, respectively, for the quarter ended July 2018. Do the numbers hold clues to what lies ahead for the stock?
Cantel Medical (CMD) Q4 Earnings Preview: What's Shaping Up?
by Zacks Equity Research
Cantel (CMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cantel Medical Corp. (CMD) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Cantel Medical Corp. (CMD) Sees Hammer Chart Pattern: Time to Buy?
Should Vanguard S&P Small-Cap 600 Growth ETF (VIOG) Be on Your Investing Radar?
by Sweta Killa
Style Box ETF report for VIOG
What Falling Estimates & Price Mean for Natus Medical (BABY)
by Zacks Equity Research
It seems to be a wise decision for investors to drop Natus Medical (BABY) stock considering its negative estimate revision, price depreciation as well as unfavorable Zacks rank.